[go: up one dir, main page]

NO994160D0 - Basisk aluminium-magnesiumkarbonat, fremgangsmåte for fremstilling derav og dets anvendelse som et farmasöytisk preparat for behandling av magesurhet - Google Patents

Basisk aluminium-magnesiumkarbonat, fremgangsmåte for fremstilling derav og dets anvendelse som et farmasöytisk preparat for behandling av magesurhet

Info

Publication number
NO994160D0
NO994160D0 NO994160A NO994160A NO994160D0 NO 994160 D0 NO994160 D0 NO 994160D0 NO 994160 A NO994160 A NO 994160A NO 994160 A NO994160 A NO 994160A NO 994160 D0 NO994160 D0 NO 994160D0
Authority
NO
Norway
Prior art keywords
preparation
treatment
magnesium carbonate
aluminum magnesium
basic aluminum
Prior art date
Application number
NO994160A
Other languages
English (en)
Other versions
NO994160L (no
Inventor
Rafael Foguet
Santiago Gubert
Aurelio Sacristan
Josep M Castello
Jose A Ortiz
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO994160D0 publication Critical patent/NO994160D0/no
Publication of NO994160L publication Critical patent/NO994160L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00—Compounds of aluminium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F7/00—Compounds of aluminium
    • C01F7/78—Compounds containing aluminium, with or without oxygen or hydrogen, and containing two or more other elements
    • C01F7/784—Layered double hydroxide, e.g. comprising nitrate, sulfate or carbonate ions as intercalating anions
    • C01F7/785—Hydrotalcite
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/77—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by unit-cell parameters, atom positions or structure diagrams
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/88—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by thermal analysis data, e.g. TGA, DTA, DSC
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/50—Agglomerated particles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Geology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
NO994160A 1997-12-30 1999-08-27 Basisk aluminium-magnesiumkarbonat, fremgangsmaate for fremstilling derav og dets anvendelse som et farmasöytisk preparat for behandling av magesurhet NO994160L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009702717A ES2133136B1 (es) 1997-12-30 1997-12-30 Nuevo carbonato basico de aluminio y magnesio.
PCT/EP1998/008498 WO1999035088A1 (en) 1997-12-30 1998-12-29 Basic aluminum magnesium carbonate, method for the preparation thereof and its use as a pharmaceutical composition for treating stomach acidity

Publications (2)

Publication Number Publication Date
NO994160D0 true NO994160D0 (no) 1999-08-27
NO994160L NO994160L (no) 1999-08-27

Family

ID=8301660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994160A NO994160L (no) 1997-12-30 1999-08-27 Basisk aluminium-magnesiumkarbonat, fremgangsmaate for fremstilling derav og dets anvendelse som et farmasöytisk preparat for behandling av magesurhet

Country Status (15)

Country Link
EP (1) EP0968133A1 (no)
JP (1) JP2001516328A (no)
KR (1) KR20000075839A (no)
AR (1) AR007232A1 (no)
AU (1) AU742544B2 (no)
BR (1) BR9807275A (no)
CA (1) CA2282361A1 (no)
ES (1) ES2133136B1 (no)
IL (1) IL131573A0 (no)
NO (1) NO994160L (no)
PA (1) PA8464401A1 (no)
PL (1) PL335464A1 (no)
RU (1) RU2168464C1 (no)
WO (1) WO1999035088A1 (no)
ZA (1) ZA9811216B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4338470B2 (ja) * 2003-08-12 2009-10-07 日鉄鉱業株式会社 ハイドロタルサイト粒子及びその製造方法
CN101039875B (zh) * 2004-10-20 2012-03-07 堺化学工业株式会社 水滑石和合成树脂组合物
RU2540635C2 (ru) * 2012-11-22 2015-02-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный минерально-сырьевой университет "Горный" Способ получения гидрокарбоалюминатов щелочноземельных металлов из природного магнийсодержащего сырья
CN108159072A (zh) * 2017-12-04 2018-06-15 上海裕英生物医药科技有限公司 铝镁加的制备工艺
RU2678007C1 (ru) * 2017-12-05 2019-01-22 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр "Кольский научный центр Российской академии наук" (ФИЦ КНЦ РАН) Способ получения слоистого гидроксида магния и алюминия

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539306A (en) * 1966-07-25 1970-11-10 Kyowa Chem Ind Co Ltd Process for the preparation of hydrotalcite
US4904457A (en) * 1974-03-30 1990-02-27 Aluminum Company Of America Synthetic hydrotalcite
GB1598375A (en) * 1978-02-17 1981-09-16 Anphar Sa Aluminium magnesium carbonate
DE3306822C2 (de) * 1983-02-26 1985-01-03 Giulini Chemie Gmbh, 6700 Ludwigshafen Kristallines, basisches Aluminium-Magnesium-Carbonat
DK167146B1 (da) * 1990-09-11 1993-09-06 Topsoe Haldor As Fremgangsmaade og katalysator til fremstilling af aromatiske forbindelser
US5364828A (en) * 1992-10-21 1994-11-15 Minerals Technologies Spheroidal aggregate of platy synthetic hydrotalcite
CZ293606B6 (cs) * 1994-08-15 2004-06-16 Aluminum Company Of America Způsob výroby vrstveného podvojného hydroxidu a hydrotalkitu podobných sloučenin ve formě prášku
DE19503522A1 (de) * 1995-02-03 1996-08-08 Rwe Dea Ag Herstellung gemischter schichtförmig aufgebauter Metallhydroxide sowie deren Metalloxide

Also Published As

Publication number Publication date
AU742544B2 (en) 2002-01-03
IL131573A0 (en) 2001-01-28
PA8464401A1 (es) 2000-09-29
RU2168464C1 (ru) 2001-06-10
WO1999035088A1 (en) 1999-07-15
NO994160L (no) 1999-08-27
KR20000075839A (ko) 2000-12-26
ES2133136A1 (es) 1999-08-16
PL335464A1 (en) 2000-04-25
ES2133136B1 (es) 2000-04-01
AU2276799A (en) 1999-07-26
JP2001516328A (ja) 2001-09-25
EP0968133A1 (en) 2000-01-05
ZA9811216B (en) 1999-07-14
AR007232A1 (es) 1999-10-27
BR9807275A (pt) 2000-05-02
CA2282361A1 (en) 1999-07-15

Similar Documents

Publication Publication Date Title
PL375789A1 (en) Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
NO20024734D0 (no) Farmasöytisk preparat for behandling av akutt, kronisk smerte og/eller neuropatisk smerte og migrener
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
IL158593A (en) Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO993519L (no) Fenofibrat farmasöytisk blanding som har höy biotilgjengelighet og fremgangsmÕte for fremstilling av den
NO20042410L (no) Sammensetning som omfatter angiopoietinliknende protein 3, ANGPTL3 og fremgangsmate til anvendelse av samme
ATE303802T1 (de) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phen l enthaltendes arzneimittel mit verzögerter wirkstofffreisetzung
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
IL164533A0 (en) Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
IL158289A (en) Mercaptoacetylamide derivatives, a process for their preparation and their use as medicaments for the treatment of hypertension and chf
HUP0300218A3 (en) Process for treatment of diabetes, employing combination of metformin and glyburide
NO20022834L (no) Zeolitt SSZ-50, fremgangsmåte for fremstilling og anvendelse av denne
HUP0102292A3 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
FI970058L (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
NO975076L (no) Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling
NO20001909L (no) FremgangsmÕte og anlegg for fremstilling av 1,2-dikloretan
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO994160D0 (no) Basisk aluminium-magnesiumkarbonat, fremgangsmåte for fremstilling derav og dets anvendelse som et farmasöytisk preparat for behandling av magesurhet
DK0727416T3 (da) Substituerede benzensulfonylurinstoffer og -thiourinstoffer, og fremgangsmåde til deres fremstilling, deres anvendelse som
NO20020784L (no) Medikament for behandling av brudd
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
NO20031108L (no) Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application